Raymond James reiterates Strong Buy on Terex stock amid selloff

Raymond James reiterated its Strong Buy rating on Terex with an $85 price target, citing a roughly 20% decline since the Fed’s Jackson Hole pivot and an estimated outsized upside-to-downside trade-off; shares were at $51.55, down nearly 31% from their 52-week high and 9.6% over the past week. Terex is selling its Genie business unit. Separately, its Q2 2026 adjusted EPS of $1.37 and revenue of $2.24 billion topped estimates of $1.25 and $2.13 billion, and it raised full-year guidance, though the stock declined in premarket trading amid concerns including tariffs and product mix.

Analysis

The key question is whether the drawdown reflects a temporary risk-premium shock or a deterioration in forward earnings power. A beat and higher guidance are backward-looking support; tariff pass-through, order momentum, product mix, and margin conversion determine whether the forward estimate base holds. If tariffs raise input costs faster than Terex can reprice, reported revenue could remain resilient while earnings quality weakens.

The Genie divestiture adds a second-order valuation issue: proceeds and the quality of the retained portfolio matter more than the headline sale. Until terms, timing, and intended use of proceeds are clear, investors may apply a conglomerate/transaction discount; a completed sale could instead sharpen the remaining business’s exposure to cyclical equipment demand. Competitors such as Oshkosh and Manitowoc may benefit if customers defer or substitute purchases, though the article provides no evidence of share gains.

Near term, positioning and rate sensitivity can keep the stock volatile despite estimates being raised. Over 1–3 months, watch guidance revisions, backlog/order commentary, tariff recovery, and divestiture execution. Over 6–18 months, the thesis depends on whether portfolio simplification improves returns through a full equipment cycle. The analyst’s target and a third-party fair-value estimate are opinions, not catalysts or independent confirmation. The contrarian opportunity is that the market may be extrapolating a macro drawdown despite improved company-specific execution; the counterpoint is that strong current results may mask weaker mix or costs ahead.

Key Decisions for Investors

• Consider a staged, modest long in TEX only if the next update confirms guidance and shows stable orders/margins; avoid treating the analyst target as a valuation floor. The setup offers rebound exposure, but cyclical and tariff risks argue against sizing it as a low-risk value trade.
• Use the next earnings or company update as the 1–3 month catalyst check: monitor backlog/order trends, price-cost recovery, product mix, and any guidance change. A downward revision or evidence of margin erosion would falsify the stabilization thesis and warrant exiting or staying sidelined.
• Track Genie sale terms, closing timetable, and proceeds deployment before assigning value to the transaction. Delay, weaker-than-expected proceeds, or unclear capital allocation would prolong the discount; a completed sale with credible use of proceeds could support a re-rating.
• No peer pair is justified from this evidence alone: verify relative valuation, end-market exposure, and order trends before expressing the view against Oshkosh or Manitowoc.